Retatrutide
An investigational peptide from Eli Lilly that acts on the GIP, GLP-1 and glucagon receptors, given as a weekly injection in clinical trials. Not approved in Canada or anywhere else; sold online as a research chemical.
Longevity0 public stacks
Substance
Retatrutide
- Route
- Injection Injected
- Measured in
- mg milligrams
- Comes as
- vial
Also
Public stacks with it 0
No public stack has it yet.